Nanopharma Technologies, Inc. is a drug development company located in Tampa
Bay,
Florida. Our mission is to develop cutting-edge technologies for the
pharmaceutical industry and the anti-bacterial market in particular.
We apply our scientific and commercial expertise to discover, acquire and develop novel compounds to be used as antibiotics and/or drug
delivery tools. Current research and development efforts are focused on a new class of narrow-spectrum antibiotics
highly specific against acute infectious diseases such as MRSA, Tuberculosis
and Anthrax, as well as a drug delivery platform using nanoparticle
technology.
